Liver Cancer Drugs market worldwide is projected to grow by US$1. 5 Billion, driven by a compounded growth of 19. 5%. Targeted Therapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 20.

New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Liver Cancer Drugs Industry" - https://www.reportlinker.com/p05818004/?utm_source=GNW
4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.3 Billion by the year 2025, Targeted Therapy will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 17.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$54.9 Million to the region’s size and clout in the next 5 to 6 years. Over US$45.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Targeted Therapy will reach a market size of US$59.9 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 24.9% over the next couple of years and add approximately US$369.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Bayer AG; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Exelixis, Inc.; Merck & Co., Inc.


Read the full report: https://www.reportlinker.com/p05818004/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Liver Cancer Drugs Competitor Market Share Scenario Worldwide
(in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Liver Cancer Drugs Global Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 2: Liver Cancer Drugs Global Retrospective Market
Scenario in US$ Thousand by Region/Country: 2009-2017
Table 3: Liver Cancer Drugs Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Targeted Therapy (Drug Class) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 5: Targeted Therapy (Drug Class) Historic Market Analysis
by Region/Country in US$ Thousand: 2009 to 2017
Table 6: Targeted Therapy (Drug Class) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Immunotherapy (Drug Class) Potential Growth Markets
Worldwide in US$ Thousand: 2018 to 2025
Table 8: Immunotherapy (Drug Class) Historic Market Perspective
by Region/Country in US$ Thousand: 2009 to 2017
Table 9: Immunotherapy (Drug Class) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Liver Cancer Drugs Market Share (in %) by Company: 2019 & 2025
Table 10: United States Liver Cancer Drugs Market Estimates and
Projections in US$ Thousand by Drug Class: 2018 to 2025
Table 11: Liver Cancer Drugs Market in the United States by
Drug Class: A Historic Review in US$ Thousand for 2009-2017
Table 12: United States Liver Cancer Drugs Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
CANADA
Table 13: Canadian Liver Cancer Drugs Market Estimates and
Forecasts in US$ Thousand by Drug Class: 2018 to 2025
Table 14: Canadian Liver Cancer Drugs Historic Market Review by
Drug Class in US$ Thousand: 2009-2017
Table 15: Liver Cancer Drugs Market in Canada: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
JAPAN
Table 16: Japanese Market for Liver Cancer Drugs: Annual Sales
Estimates and Projections in US$ Thousand by Drug Class for the
Period 2018-2025
Table 17: Liver Cancer Drugs Market in Japan: Historic Sales
Analysis in US$ Thousand by Drug Class for the Period 2009-2017
Table 18: Japanese Liver Cancer Drugs Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
CHINA
Table 19: Chinese Liver Cancer Drugs Market Growth Prospects in
US$ Thousand by Drug Class for the Period 2018-2025
Table 20: Liver Cancer Drugs Historic Market Analysis in China
in US$ Thousand by Drug Class: 2009-2017
Table 21: Chinese Liver Cancer Drugs Market by Drug Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Liver Cancer Drugs Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 22: European Liver Cancer Drugs Market Demand Scenario in
US$ Thousand by Region/Country: 2018-2025
Table 23: Liver Cancer Drugs Market in Europe: A Historic
Market Perspective in US$ Thousand by Region/Country for the
Period 2009-2017
Table 24: European Liver Cancer Drugs Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 25: European Liver Cancer Drugs Market Estimates and
Forecasts in US$ Thousand by Drug Class: 2018-2025
Table 26: Liver Cancer Drugs Market in Europe in US$ Thousand
by Drug Class: A Historic Review for the Period 2009-2017
Table 27: European Liver Cancer Drugs Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
FRANCE
Table 28: Liver Cancer Drugs Market in France by Drug Class:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 29: French Liver Cancer Drugs Historic Market Scenario in
US$ Thousand by Drug Class: 2009-2017
Table 30: French Liver Cancer Drugs Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
GERMANY
Table 31: Liver Cancer Drugs Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Drug Class for
the Period 2018-2025
Table 32: German Liver Cancer Drugs Historic Market Analysis in
US$ Thousand by Drug Class: 2009-2017
Table 33: German Liver Cancer Drugs Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
ITALY
Table 34: Italian Liver Cancer Drugs Market Growth Prospects in
US$ Thousand by Drug Class for the Period 2018-2025
Table 35: Liver Cancer Drugs Historic Market Analysis in Italy
in US$ Thousand by Drug Class: 2009-2017
Table 36: Italian Liver Cancer Drugs Market by Drug Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 37: United Kingdom Market for Liver Cancer Drugs: Annual
Sales Estimates and Projections in US$ Thousand by Drug Class
for the Period 2018-2025
Table 38: Liver Cancer Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Thousand by Drug Class for the
Period 2009-2017
Table 39: United Kingdom Liver Cancer Drugs Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
SPAIN
Table 40: Spanish Liver Cancer Drugs Market Estimates and
Forecasts in US$ Thousand by Drug Class: 2018 to 2025
Table 41: Spanish Liver Cancer Drugs Historic Market Review by
Drug Class in US$ Thousand: 2009-2017
Table 42: Liver Cancer Drugs Market in Spain: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
RUSSIA
Table 43: Russian Liver Cancer Drugs Market Estimates and
Projections in US$ Thousand by Drug Class: 2018 to 2025
Table 44: Liver Cancer Drugs Market in Russia by Drug Class: A
Historic Review in US$ Thousand for 2009-2017
Table 45: Russian Liver Cancer Drugs Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 46: Rest of Europe Liver Cancer Drugs Market Estimates
and Forecasts in US$ Thousand by Drug Class: 2018-2025
Table 47: Liver Cancer Drugs Market in Rest of Europe in US$
Thousand by Drug Class: A Historic Review for the Period
2009-2017
Table 48: Rest of Europe Liver Cancer Drugs Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 49: Asia-Pacific Liver Cancer Drugs Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 50: Liver Cancer Drugs Market in Asia-Pacific: Historic
Market Analysis in US$ Thousand by Region/Country for the
Period 2009-2017
Table 51: Asia-Pacific Liver Cancer Drugs Market Share Analysis
by Region/Country: 2009 VS 2019 VS 2025
Table 52: Liver Cancer Drugs Market in Asia-Pacific by Drug
Class: Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 53: Asia-Pacific Liver Cancer Drugs Historic Market
Scenario in US$ Thousand by Drug Class: 2009-2017
Table 54: Asia-Pacific Liver Cancer Drugs Market Share Analysis
by Drug Class: 2009 VS 2019 VS 2025
AUSTRALIA
Table 55: Liver Cancer Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Thousand by Drug Class for
the Period 2018-2025
Table 56: Australian Liver Cancer Drugs Historic Market
Analysis in US$ Thousand by Drug Class: 2009-2017
Table 57: Australian Liver Cancer Drugs Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
INDIA
Table 58: Indian Liver Cancer Drugs Market Estimates and
Forecasts in US$ Thousand by Drug Class: 2018 to 2025
Table 59: Indian Liver Cancer Drugs Historic Market Review by
Drug Class in US$ Thousand: 2009-2017
Table 60: Liver Cancer Drugs Market in India: Percentage Share
Breakdown of Sales by Drug Class for 2009, 2019, and 2025
SOUTH KOREA
Table 61: Liver Cancer Drugs Market in South Korea: Recent
Past, Current and Future Analysis in US$ Thousand by Drug Class
for the Period 2018-2025
Table 62: South Korean Liver Cancer Drugs Historic Market
Analysis in US$ Thousand by Drug Class: 2009-2017
Table 63: Liver Cancer Drugs Market Share Distribution in South
Korea by Drug Class: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 64: Rest of Asia-Pacific Market for Liver Cancer Drugs:
Annual Sales Estimates and Projections in US$ Thousand by Drug
Class for the Period 2018-2025
Table 65: Liver Cancer Drugs Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Thousand by Drug Class for the
Period 2009-2017
Table 66: Rest of Asia-Pacific Liver Cancer Drugs Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 67: Latin American Liver Cancer Drugs Market Trends by
Region/Country in US$ Thousand: 2018-2025
Table 68: Liver Cancer Drugs Market in Latin America in US$
Thousand by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 69: Latin American Liver Cancer Drugs Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 70: Latin American Liver Cancer Drugs Market Growth
Prospects in US$ Thousand by Drug Class for the Period
2018-2025
Table 71: Liver Cancer Drugs Historic Market Analysis in Latin
America in US$ Thousand by Drug Class: 2009-2017
Table 72: Latin American Liver Cancer Drugs Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 73: Argentinean Liver Cancer Drugs Market Estimates and
Forecasts in US$ Thousand by Drug Class: 2018-2025
Table 74: Liver Cancer Drugs Market in Argentina in US$
Thousand by Drug Class: A Historic Review for the Period
2009-2017
Table 75: Argentinean Liver Cancer Drugs Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
BRAZIL
Table 76: Liver Cancer Drugs Market in Brazil by Drug Class:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 77: Brazilian Liver Cancer Drugs Historic Market Scenario
in US$ Thousand by Drug Class: 2009-2017
Table 78: Brazilian Liver Cancer Drugs Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
MEXICO
Table 79: Liver Cancer Drugs Market in Mexico: Recent Past,
Current and Future Analysis in US$ Thousand by Drug Class for
the Period 2018-2025
Table 80: Mexican Liver Cancer Drugs Historic Market Analysis
in US$ Thousand by Drug Class: 2009-2017
Table 81: Mexican Liver Cancer Drugs Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 82: Rest of Latin America Liver Cancer Drugs Market
Estimates and Projections in US$ Thousand by Drug Class: 2018
to 2025
Table 83: Liver Cancer Drugs Market in Rest of Latin America by
Drug Class: A Historic Review in US$ Thousand for 2009-2017
Table 84: Rest of Latin America Liver Cancer Drugs Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 85: The Middle East Liver Cancer Drugs Market Estimates
and Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 86: Liver Cancer Drugs Market in the Middle East by
Region/Country in US$ Thousand: 2009-2017
Table 87: The Middle East Liver Cancer Drugs Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 88: The Middle East Liver Cancer Drugs Market Estimates
and Forecasts in US$ Thousand by Drug Class: 2018 to 2025
Table 89: The Middle East Liver Cancer Drugs Historic Market
by Drug Class in US$ Thousand: 2009-2017
Table 90: Liver Cancer Drugs Market in the Middle East:
Percentage Share Breakdown of Sales by Drug Class for 2009,
2019, and 2025
IRAN
Table 91: Iranian Market for Liver Cancer Drugs: Annual Sales
Estimates and Projections in US$ Thousand by Drug Class for the
Period 2018-2025
Table 92: Liver Cancer Drugs Market in Iran: Historic Sales
Analysis in US$ Thousand by Drug Class for the Period 2009-2017
Table 93: Iranian Liver Cancer Drugs Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
ISRAEL
Table 94: Israeli Liver Cancer Drugs Market Estimates and
Forecasts in US$ Thousand by Drug Class: 2018-2025
Table 95: Liver Cancer Drugs Market in Israel in US$ Thousand
by Drug Class: A Historic Review for the Period 2009-2017
Table 96: Israeli Liver Cancer Drugs Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 97: Saudi Arabian Liver Cancer Drugs Market Growth
Prospects in US$ Thousand by Drug Class for the Period
2018-2025
Table 98: Liver Cancer Drugs Historic Market Analysis in Saudi
Arabia in US$ Thousand by Drug Class: 2009-2017
Table 99: Saudi Arabian Liver Cancer Drugs Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 100: Liver Cancer Drugs Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Thousand by Drug Class for the Period 2018-2025
Table 101: United Arab Emirates Liver Cancer Drugs Historic
Market Analysis in US$ Thousand by Drug Class: 2009-2017
Table 102: Liver Cancer Drugs Market Share Distribution in
United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 103: Liver Cancer Drugs Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Thousand by
Drug Class for the Period 2018-2025
Table 104: Rest of Middle East Liver Cancer Drugs Historic
Market Analysis in US$ Thousand by Drug Class: 2009-2017
Table 105: Rest of Middle East Liver Cancer Drugs Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
AFRICA
Table 106: African Liver Cancer Drugs Market Estimates and
Projections in US$ Thousand by Drug Class: 2018 to 2025
Table 107: Liver Cancer Drugs Market in Africa by Drug Class: A
Historic Review in US$ Thousand for 2009-2017
Table 108: African Liver Cancer Drugs Market Share Breakdown by
Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

BAYER AG
BRISTOL-MYERS SQUIBB COMPANY
EISAI CO.
EXELIXIS
MERCK & CO., INC.

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818004/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001